World's Best Scientists 2026 revealed!

D-Index & Metrics

Neuroscience

D-Index
48
Citations
8923
World Ranking
6183
National Ranking
47

Overview

Sargo Aalto is affiliated with the University of Turku in Finland. Their academic work is associated with this institution, where they contribute to research activities and knowledge development in relevant fields.

Although specific details about Sargo Aalto's published papers are not available, they have an established presence within academic circles. There are no records of recent papers, co-authors, or frequent publication venues connected to their name in the provided data.

The scientist's fields of study and subfields of study are not documented in the available information. Similarly, there is no detailed list of main topics of their research or the subjects they have focused on throughout their career.

There is no information about book publications or awards granted to Sargo Aalto. The data does confirm that they are currently alive.

This overview is based on the collected professional and academic data, focusing on affiliation and available records without speculative additions, maintaining a factual and impartial presentation.

Best Publications

  • Effects of sevoflurane, propofol, and adjunct nitrous oxide on regional cerebral blood flow, oxygen consumption, and blood volume in humans

    Kaike K. Kaisti;Jaakko W. Långsjö;Sargo Aalto;Vesa Oikonen

  • Frontal and temporal dopamine release during working memory and attention tasks in healthy humans: a positron emission tomography study using the high-affinity dopamine D2 receptor ligand [11C]FLB 457.

    Sargo Aalto;Anna Brück;Matti Laine;Kjell Någren

  • PET amyloid ligand [11C]PIB uptake is increased in mild cognitive impairment.

    N. M. Kemppainen;S. Aalto;I. A. Wilson;K. Någren

  • Striatal dopamine D1 and D2 receptors in burning mouth syndrome.

    Nora Hagelberg;Heli Forssell;Juha O Rinne;Harry Scheinin

  • Effects of Surgical Levels of Propofol and Sevoflurane Anesthesia on Cerebral Blood Flow in Healthy Subjects Studied with Positron Emission Tomography

    Kaike K. Kaisti;Liisa Metsähonkala;Mika Teräs;Vesa Oikonen

  • Cognitive reserve hypothesis: Pittsburgh Compound B and fluorodeoxyglucose positron emission tomography in relation to education in mild Alzheimer's disease

    Nina M. Kemppainen;Sargo Aalto;Sargo Aalto;Mira Karrasch;Kjell Någren

  • Assessment of beta-amyloid in a frontal cortical brain biopsy specimen and by positron emission tomography with carbon 11-labeled Pittsburgh Compound B.

    Ville Leinonen;Irina Alafuzoff;Sargo Aalto;Timo Suotunen

  • Voxel-based analysis of PET amyloid ligand [11C]PIB uptake in Alzheimer disease

    N. M. Kemppainen;S. Aalto;I. A. Wilson;K. Någren

  • Altered dopamine D2 receptor binding in atypical facial pain.

    Nora Hagelberg;Heli Forssell;Sargo Aalto;Juha O. Rinne

  • Effects of subanesthetic doses of ketamine on regional cerebral blood flow, oxygen consumption, and blood volume in humans.

    Jaakko W. Långsjö;Kaike K. Kaisti;Sargo Aalto;Susanna Hinkka

  • Returning from Oblivion: Imaging the Neural Core of Consciousness

    Jaakko W. Långsjö;Michael T. Alkire;Kimmo Kaskinoro;Hiroki Hayama

  • Impaired cognitive performance in Parkinson's disease is related to caudate dopaminergic hypofunction and hippocampal atrophy

    Pekka Jokinen;Anna Brück;Sargo Aalto;Sarita Forsback

  • Amyloid PET imaging in patients with mild cognitive impairment: a 2-year follow-up study.

    J Koivunen;N Scheinin;J R Virta;S Aalto

  • High intensity exercise decreases global brain glucose uptake in humans.

    Jukka Kemppainen;Sargo Aalto;Toshihiko Fujimoto;Kari K. Kalliokoski

  • Increased caudate dopamine D2 receptor availability as a genetic marker for schizophrenia

    Jussi Hirvonen;Theo G. M. van Erp;Jukka Huttunen;Sargo Aalto

  • S -Ketamine Anesthesia Increases Cerebral Blood Flow in Excess of the Metabolic Needs in Humans

    Jaakko W. Långsjö;Anu Maksimow;Elina Salmi;Kaike Kaisti

  • Mobile Phone Affects Cerebral Blood Flow in Humans

    Sargo Aalto;Christian Haarala;Anna Brück;Hannu Sipilä

  • Cortical 6-[18F]fluoro-l-dopa uptake and frontal cognitive functions in early Parkinson's disease

    Anna Brück;Sargo Aalto;Elina Nurmi;Jörgen Bergman

  • Expectation of caffeine induces dopaminergic responses in humans

    Valtteri Kaasinen;Sargo Aalto;Kjell Någren;Juha O. Rinne

  • Follow-up of [11C]PIB uptake and brain volume in patients with Alzheimer disease and controls

    NM Scheinin;S Aalto;J Koikkalainen;J Lötjönen

Frequent Co-Authors

Juha O. Rinne
Juha O. Rinne Turku University Hospital
Harry Scheinin
Harry Scheinin Turku University Hospital
Jussi Hirvonen
Jussi Hirvonen Turku University Hospital
Riitta Parkkola
Riitta Parkkola Turku University Hospital
Valtteri Kaasinen
Valtteri Kaasinen Turku University Hospital
Theo G.M. van Erp
Theo G.M. van Erp University of California, Irvine
Tuula Pirttilä
Tuula Pirttilä University of Eastern Finland
Esa R. Korpi
Esa R. Korpi University of Helsinki
Matti Laine
Matti Laine Åbo Akademi University
Anthony S. Joyce
Anthony S. Joyce University of Alberta

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Best Scientists Citing Sargo Aalto